Prestigious Sports Medicine Journal Retracts Articles Authored by Former Editor-in-Chief
TUESDAY, Oct. 11, 2022 (HealthDay News) — A leading medical journal, the British Journal of Sports Medicine, has retracted nine more articles written by its former editor-in-chief and applied “expressions of concern” on 38 additional articles on whic…
Learn More7 Million U.S. Women Live in Maternity Care ‘Deserts’
TUESDAY, Oct. 11, 2022 (HealthDay News) — The United States is still among one of the most dangerous developed nations for childbirth, especially in rural areas and communities of color, according to a new March of Dimes report. About 36 percent of U…
Learn MoreUSPSTF Recommends Depression, Anxiety Screening for Teens
TUESDAY, Oct. 11, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends screening for major depressive disorder (MDD) in adolescents aged 12 to 18 years and for anxiety in children aged 8 to 18 years. These recommendatio…
Learn MoreCRC Risk Modestly Reduced for Those Invited to Screening Colonoscopy
TUESDAY, Oct. 11, 2022 (HealthDay News) — Participants who are invited to undergo screening colonoscopy have a reduced risk for colorectal cancer at 10 years but no reduction in the risk for death from colorectal cancer, according to a study publishe…
Learn MoreInflammatory Bowel Disease Tied to More Gum Disease
TUESDAY, Oct. 11, 2022 (HealthDay News) — Patients with inflammatory bowel disease (IBD) have a significantly higher frequency of periodontitis than healthy controls, according to a study published online Sept. 16 in the Journal of Periodontology.Gia…
Learn MoreCefepime/Enmetazobactam Noninferior for Complicated UTI
TUESDAY, Oct. 11, 2022 (HealthDay News) — For patients with complicated urinary tract infection (UTI) or acute pyelonephritis caused by gram-negative pathogens, cefepime/enmetazobactam is noninferior and superior to piperacillin/tazobactam for clinic…
Learn MoreAntenatal Steroids May Improve Outcomes in Extreme Preemies
TUESDAY, Oct. 11, 2022 (HealthDay News) — Exposure to a complete course of antenatal steroids is independently associated with greater odds of survival and survival without major morbidity among extremely preterm infants, according to a study publish…
Learn MoreLenabasum Studied for Refractory Cutaneous Dermatomyositis
TUESDAY, Oct. 11, 2022 (HealthDay News) — Lenabasum is well tolerated for the treatment of amyopathic dermatomyositis, according to a phase 2 study published online Oct. 1 in the Journal of Investigative Dermatology.Victoria P. Werth, M.D., from the …
Learn MoreRisk for Type 1 Diabetes in Children May Rise After COVID-19
TUESDAY, Oct. 11, 2022 (HealthDay News) — Risk for a new diagnosis of type 1 diabetes (T1D) may persist for up to six months following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children, according to a research letter …
Learn MoreFunctional Stroke Recovery Varies by Age, Sex, and Stroke Type
TUESDAY, Oct. 11, 2022 (HealthDay News) — Following stroke, long-term recovery patterns in multifaceted functional domains differ by patient age, stroke severity, and stroke type, according to a study published online Sept. 23 in JAMA Network Open.Se…
Learn More